Navigation Links
Direct-to-consumer advertising for genetic tests concerns physicians and may mislead patients
Date:11/29/2007

Direct-to-consumer advertising for commercial genetic testing is on the rise and may be problematic, according to a Massachusetts General Hospital (MGH) physician. In the December issue of Obstetrics & Gynecology, Erin Tracy, MD, MPH, warns that such testing is poorly regulated and may present potential pitfalls for patients and physicians.

Some of the tests that are being offered have no proven clinical validity whatsoever and are quite costly, says Tracy. So patients spend money trying to identify a particular gene to figure out if their child is prone to addictive behavior, for example. If the test comes back positive, parents are often not adequately counseled as to what those results might mean, whether these tests have any proven value, or what resources are available for follow up."

The majority of DNA tests are home brews that are unregulated by the FDA, Tracy explains. While the FDA needs more funding to regulate genetic testing, it also is limited in its ability to regulate services based in other countries. According to a 2002 study in Genetics in Medicine, 24 of 105 web sites offering genetic testing directed potential clients to international mailing addresses. Many sites listed professional societies or accrediting organizations on their pages, implying sponsorship or approval of their activities that may not be accurate.

Like other direct-to-consumer ads, these materials do not need to be reviewed by the FDA before they are published. Many involve emotional appeals such as placing an ad for a cancer-associated gene test in the program of a play about a woman dying from ovarian cancer instead of clear discussion of the rationale for screening. Results of genetic tests have the potential to cause excessive alarm or to falsely assure consumers that they will not develop cancer or disease. Direct-to-consumer advertising for genetic tests may also give the erroneous impression that a certain test is mandatory.

Some patients with no risk factors for breast cancer come in and request the test for BRCA-1 and BRCA-2 mutations, says Tracy, referring to a recent advertising campaign. The ads are compelling and theyre emotionally driven. I end up spending time discussing why a particular test being advertised is not appropriate when I should be addressing important issues such as eating a healthy diet or smoking cessation. At the same time, she notes, without proper counseling a patient who does not have the BRCA-1 or BRCA-2 mutations might assume she has no risk for breast cancer and forgo recommended mammograms and clinical breast examinations.

In order to make an informed decision about genetic tests, patients should consult with their physicians about their particular risk for cancer or other diseases, Tracy says. Before any test is ordered, there should be a thought process about whether that particular test is appropriate and what well do with it. And physicians need to stay current about whats out there so we can best advise our patients.


'/>"/>

Contact: Valerie Wencis
vwencis@partners.org
617-726-0274
Massachusetts General Hospital
Source:Eurekalert

Related biology news :

1. Does the desire to consume alcohol and tobacco come from our genetic makeup?
2. Diverse genetic abnormalities lead to NF-κB activation in multiple myeloma
3. Many parents at-risk for cancer disclose genetic test results to children
4. Genetics determine optimal drug dose of common anticoagulant
5. Claims of sex-related differences in genetic association studies often not properly validated
6. American College of Medical Genetics responds to new FDA labeling decision for warfarin
7. UNC study questions FDA genetic-screening guidelines for cancer drug
8. Genome study shines light on genetic link to height
9. Selexis Announces Advanced Approach to Maximize Power of Genetic Elements for Rapid Development of High Performance Cell Lines
10. Genes, Environment and Health Initiative invests in genetic studies, environmental monitoring
11. Rutgers Genetics receives $7.8 million for autism research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2020)... FREDERICA, Del. (PRWEB) , ... April 29, 2020 ... ... was well positioned for continued growth – delivering innovative solutions for a ... personal care, chemical, aerospace and government agencies. A month into the new decade, ...
(Date:4/23/2020)... ... April 23, 2020 , ... Despite the ... provides critical infrastructure products for the animal feed, human consumption, wastewater, and biotech ... Further, as supply channels from overseas competitors have become weakened or shut down ...
(Date:4/22/2020)... ... April 21, 2020 , ... Worcester Polytechnic Institute (WPI) ... provide critical medical supplies to address the expected spike of COVID-19 cases. As part ... WPI has arranged for 3D printers and other materials to be sent to six ...
Breaking Biology News(10 mins):
(Date:5/9/2020)... ... ... Worldwide Business with kathy ireland® will be LIVE streaming ... and Wednesday, May 13, 2020 at 8:00pm ET / PT – prime time ... Techolution and Bravado Pharmaceuticals . , As leaders in their ...
(Date:5/5/2020)... ... May 05, 2020 , ... ProductLife Group has marked the next ... the group after 13 years at Altran, where he was Group VP of Life ... and being a Pharmacist, Xavier was involved in his early career in the development ...
(Date:5/1/2020)... (PRWEB) , ... April 30, 2020 , ... ... were announced today, honoring the businesses, policies, projects, and concepts that are actively ... revolutionary bioprinter for living cells, which has taken out the top prize in ...
(Date:4/23/2020)... (PRWEB) , ... April 22, 2020 , ... ... equipment for healthcare providers to protect themselves from COVID-19. Virginia has only been ... the Federal Emergency Management Association (FEMA). , As Governor Northam told the Virginia ...
Breaking Biology Technology: